Meeting
2022 ASCO Annual Meeting
Targeting adiposity and inflammation with movement to improve prognosis in breast cancer survivors (the AIM trial): Rationale, design, and methods.
Authors
Christina Marie Dieli-Conwright
Dana-Farber Cancer Institute, Boston, MA
Christina Marie Dieli-Conwright , Dong-Woo Kang , Rebekah M Wilson , Paola Gonzalo-Encabo , Mary Norris , Marybeth Hans , Meghan Tahbaz , Jackie Dawson , Danny Nguyen , Amber Normann , Alexandra G Yunker , Nathalie Sami , Hajime Uno , Jennifer A. Ligibel , Steven D Mittelman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT03091842
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS12140)
DOI
10.1200/JCO.2022.40.16_suppl.TPS12140
Abstract #
TPS12140
Poster Bd #
383a
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
The effect of longitudinal exercise programming in breast cancer patients.
First Author: Jami Aya Fukui
Poster
2023 ASCO Annual Meeting
Associations between body mass index with cancer recurrence and all-cause mortality among survivors of breast cancer.
First Author: Po-Hua Chen
Poster
2022 ASCO Annual Meeting
Use of the ORBIT model to refine and test a novel approach to exercise promotion for breast cancer survivors based on affect regulation.
First Author: Mary D. Chamberlin
Poster
2022 ASCO Annual Meeting
Impact of circuit, interval-based exercise on insulin resistance and adiponectin among minority cancer survivors.
First Author: Cameron Christopher